| empirical monotherapy with meropenem or combination therapy: the microbiological point of view. | the increase in the number of clinical isolates of multiresistant enterobacteriaceae and pseudomonas aeruginosa raises problems in decision-making on empirical treatments for severe gram-negative bacilli-associated infections. the aim of our study is to determine the resistance of meropenem in our setting and the co-resistance of a combination of this compound with two antibiotics from different families: amikacin and ciprofloxacin. between 2009 and 2013, a total of 81,310 clinical isolates belo ... | 2016 | 27503076 |